Luces y sombras de la medicina basada en la evidencia: el ejemplo del accidente vascular cerebral

1997, 22 Mart ínez de Aragón, 1995, Mortalidad en España en 1992, Bolet ín Epidemiológico Semanal, 3, 153 Ackerknecht, 1953, Rudolf Virchow Ackerknecht, 1967, Medicine at the Paris Hospital, 1794-1848 Cunningham, 1992, Introduction, 1 Lilienfeld, 1982, ‘Ceteris paribus’: the evolution of the clinical trial, Bulletin of the History of Medicine, 56, 1 Booth, 1993, Clinical research, 205 Marks, 2000, Trust and mistrust in the marketplace: statistics and clinical research, 1945-1960, History of Science, 38, 343, 10.1177/007327530003800304 1997, 15 Daston, 1992, The image of objectivity, Representations, 40, 81, 10.1525/rep.1992.40.1.99p0137h Gol-Freixa, 1997, Bienvenidos a la medicina basada en la evidencia. Evidence-Based Medicine Working Group, 5 Gol-Freixa, 1999, El fenómeno de la «medicina basada en la evidencia», Med Clin (Barc), 112, 3 Pozo Rodríguez, 1999, La medicina basada en la evidencia. Una perspectiva desde la clínica, Med Clin (Barc), 112, 12 Dunbabin, 1990, Preventing stroke by modification of risk factors, Stroke, 21, 36 1994, Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, Br Med J, 308, 81, 10.1136/bmj.308.6921.81 Algra, 1996, Aspirin at any dose above 30 mg offers only modest protection after cerebral ischemia, J Neurol Neurosurg Psychiatry, 60, 197, 10.1136/jnnp.60.2.197 1996, CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Diener, 1996, European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke, J Neurol Sci, 143, 1, 10.1016/S0022-510X(96)00308-5 Chamorro, 1999, Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study, J Neurol Sci, 171, 110, 10.1016/S0022-510X(99)00260-9 Masuhr, 1998, Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe, Stroke, 29, 339, 10.1161/01.STR.29.2.339 Forette, 1998, Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, Lancet, 352, 1347, 10.1016/S0140-6736(98)03086-4 Furlan, 1999, Intra-arterial prourokynase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial, JAMA, 282, 2003, 10.1001/jama.282.21.2003 Caro, 1999, Am J Med, 107, 568, 10.1016/S0002-9343(99)00295-8 Gage, 2000, Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation, Stroke, 31, 822, 10.1161/01.STR.31.4.822 Cabana, 1999, Why don´t physicians follow clinical practice guidelines? A framework for improvement, JAMA, 282, 1458, 10.1001/jama.282.15.1458 Frith, 1999, Evidence-based medicine and general practice, 29 Dowrick, 1999, Uncertainty and responsibility, 13 Dworkin, 1994, El dominio de la vida